Decitabine and Talazoparib in Untreated AML and R/R AML

NCT02878785 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Decitabine
DRUG: talazoparib

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]
[object Object]